Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis

Journal of Vascular Surgery

Volumn 59, Issue 3, 2014, Pages 761-767

  Nakagawa, Ichiro ^a   Wada, Takeshi ^a   Park, Hun Soo ^a   Nishimura, Fumihiko ^a   Yamada, Syuichi ^a   Nakagawa, Hiroyuki ^a   Kichikawa, Kimihiko ^a   Nakase, Hiroyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOPLASTY; ASPIRIN; BRAIN ISCHEMIA; CAROTID STENOSIS; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; STENTS; TETRAZOLES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894560365     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.09.011     Document Type: Article

References (31)

1. D.L. Bhatt, S.R. Kapadia, C.T. Bajzer, D.P. Chew, K.M. Ziada, and D. Mukherjee et al. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting J Invasive Cardiol 13 2001 767 771
2. S. Chaturvedi, and J.S. Yadav The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention Stroke 37 2006 1572 1577
3. T.G. Brott, R.W. Hobson, G. Howard, G.S. Roubin, W.M. Clark, and W. Brooks et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis N Engl J Med 363 2010 11 23
4. M. Cohen Antiplatelet therapy in percutaneous coronary intervention: A critical review of the 2007 AHA/ACC/SCAI guidelines and beyond Catheter Cardiovasc Interv 74 2009 579 597
5. J.T. Fifi, C. Brockington, J. Narang, W. Leesch, S.L. Ewing, and H. Bennet et al. Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting AJNR Am J Neuroradiol 34 2013 716 720
6. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, J.W. Jukema, and M.V. Huisman Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis Am Heart J 154 2007 221 231
7. J.S. Jang, H.Y. Jin, J.S. Seo, T.H. Yang, D.K. Kim, and D.S. Kim et al. A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation Cardiology 122 2007 133 143
8. K. Takayama, T. Taoka, H. Nakagawa, K. Myouchin, T. Wada, and M. Sakamoto et al. Effect of cilostazol in preventing restenosis after carotid artery stenting using the carotid wallstent: a multicenter retrospective study AJNR Am J Neuroradiol 33 2013 2167 2170
9. D.F. Geng, M. Liu, D.M. Jin, W. Wu, J. Deng, and J.F. Wang Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5821 patients Cardiology 122 2012 148 157
10. J.S. Yadav, M.H. Wholey, R.E. Kuntz, P. Fayad, B.T. Katzen, and G.J. Mishkel et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med 351 2004 1493 1501
11. R. Marcucci, A.M. Gori, R. Paniccia, B. Giusti, S. Valente, and C. Giglioli et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to adp detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
12. M. Kazui, Y. Nishiya, T. Ishizuka, K. Hagihara, N.A. Farid, and O. Okazaki et al. Identification of the human cytochrome p450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite Drug Metab Dispos 38 2010 92 99
13. Y. Yamaguchi, T. Abe, Y. Sato, Y. Matsubara, T. Moriki, and M. Murata Effects of VerifyNow p2y12 test and cyp2c19*2 testing on clinical outcomes of patients with cardiovascular disease: a systematic review and meta-analysis Platelets 24 2013 352 361
14. Y.H. Jeong, J.Y. Hwang, I.S. Kim, Y. Park, S.J. Hwang, and S.W. Lee et al. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study Circ Cardiovasc Interv 3 2011 17 26
15. J.C. Wang, D. Aucoin-Barry, D. Manuelian, R. Monbouquette, M. Reisman, and W. Gray et al. Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA Am J Cardiol 92 2003 1492 1494
16. A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-p2y12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
17. Y.S. Lee, H.J. Bae, D.W. Kang, S.H. Lee, K. Yu, and J.M. Park et al. Cilostazol in acute ischemic stroke treatment (CAIST Trial): a randomized double-blind non-inferiority trial Cerebrovasc Dis 32 2011 65 71
18. Y. Shinohara, Y. Katayama, S. Uchiyama, T. Yamaguchi, S. Handa, and K. Matsuoka et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial Lancet Neurol 9 2008 959 968
19. I.S. Kim, Y.H. Jeong, Y. Park, K.S. Park, S.E. Yun, and J.R. Park et al. Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome p450 2c19 genotype JACC Cardiovasc Interv 4 2011 381 391
20. S. Pattanaik, S. Malhotra, Y.P. Sharma, J. Ahluwalia, A. Bhalla, and P. Pandhi Effect of cilostazol on platelet aggregation in patients with non-ST elevation acute coronary syndrome Int J Clin Pharmacol Ther 48 2010 93 102
21. J.W. Suh, S.P. Lee, K.W. Park, H.Y. Lee, H.J. Kang, and B.K. Koo et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting STent implantation) trial J Am Coll Cardiol 57 2011 280 289
22. Z. Chen, J. Qian, Y. Chen, J. Ma, and J. Ge Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis J Clin Pharmacol 53 2013 532 539
23. H. Maruyama, H. Takeda, T. Dembo, H. Nagoya, Y. Kato, and T. Fukuoka et al. Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow p2y12 assay Intern Med 50 2011 695 698
24. J.E. Barbato, E. Dillavou, M.B. Horowitz, T.G. Jovin, E. Kanal, and S. David et al. A randomized trial of carotid artery stenting with and without cerebral protection J Vasc Surg 47 2008 760 765
25. S. Macdonald, D.H. Evans, P.D. Griffiths, F.M. McKevitt, G.S. Venables, and T.J. Cleveland et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial Cerebrovasc Dis 29 2012 282 289
26. P. Pinero, A. Gonzalez, A. Mayol, E. Martinez, J.R. Gonzalez-Marcos, and F. Boza et al. Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study AJNR Am J Neuroradiol 27 2006 1338 1345
27. M. Schluter, T. Tubler, J.C. Steffens, D.G. Mathey, and J. Schofer Focal ischemia of the brain after neuroprotected carotid artery stenting J Am Coll Cardiol 42 2003 1007 1013
28. D. Stojanov, M. Ilic, P. Bosnjakovic, M. Zivkovic, S. Jolic, and N. Vukasinovic et al. New ischemic brain lesions on diffusion-weighted mri after carotid artery stenting with filter protection: frequency and relationship with plaque morphology AJNR Am J Neuroradiol 33 2006 708 714
29. V. Iyer, G. de Donato, K. Deloose, P. Peeters, F. Castriota, and A. Cremonesi et al. The type of embolic protection does not influence the outcome in carotid artery stenting J Vasc Surg 46 2007 251 256
30. S.T. Pendlebury, and P.M. Rothwell Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis Lancet Neurol 8 2009 1006 1018
31. Y. Huang, Y. Cheng, J. Wu, Y. Li, E. Xu, and Z. Hong et al. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study Lancet Neurol 7 2008 494 499